In the spirit of hastening the UK’s acceptance of all crop biotechnology, I recently partnered with the London-based Adam Smith Institute to produce a new report titled Splice of Life: The case for GMOs and gene editing. In it, I survey more than two decades’ worth of research documenting the benefits of growing and consuming GMOs. The key takeaways are as follows:

• GMOs save global consumers up to $24 billion per year, while the UK farming industry has lost £1.7 billion due to their GMO ban since 1996.
• GMOs have led to an 8.6 percent decrease in global pesticide use, representing roughly 800 million fewer kilograms of insecticides and herbicides — a 19 percent reduction in the environmental impact of pesticide use since 1996.
• Between 1996 to 2018, GMOs are responsible for 34.2 million kilograms less carbon dioxide.
• GMOs are safe for human consumption and help promote sustainable agriculture. More than 2,000 studies have confirmed that approved GMO crops pose no greater threat to human health or the environment than plants produced through other breeding methods.
• There is a near-universal prohibition of genetic engineering across the European Union based on the ‘precautionary principle.’ Hypocritically, the EU still imports around 30 million metric tons of soybean and soybean meal annually, 90-95% of which is GMO.
• In his first speech as UK prime minister in 2019, Boris Johnson promised to “liberate the UK’s extraordinary bioscience sector from anti–genetic modification rules.”

How could the UK so liberate its biotech industry? I argue that the ideal regulatory framework is a case-by-case risk assessment that evaluates each novel organism based on the harms it may pose to humans and the environment, regardless of which breeding method produced it. The organism’s characteristics and intended use would determine the degree of scrutiny applied by regulators.

Matt Ridley, legendary science writer and member of the UK’s House of Lords, had this to say about Splice of Life:

“The government’s sluggishness in embracing gene engineering is disappointing. This technology, in which Britain could be world-leading, provides immense benefits to farmers, consumers and the environment. Yet, as this important new report from the Adam Smith Institute highlights, gene editing will be severely hampered and GMOs will be left behind. Scientific evidence, not activist superstition, should be at the centre of policy making.

Notes: